Articles

SPCs: Waive goodbye to your protection

In Europe, Supplementary Protection Certificates (SPCs) compensate patentees for the inevitable delay in obtaining Marketing Authorisation by extending exclusivity for a marketable pharmaceutical or plant protection product by up to five years (five-and-a-half years for paediatric medicines) following the expiry of the related patent protection. Earlier this year, the EU...

Read more

Lowering the bar to purity claims

Every so often, the European Patent Office issues a decision on a case which has important consequences for other patent applicants. The recent decision T1085/13 (discussed in greater detail here) has implications for how purity claims are assessed at the EPO and may be seen as patentee-friendly, particularly for the...

Read more

The impact of AI-generated in silico data on pharma patent applications

This article was originally posted in Drug Discovery Today and remains their copyrighted material. Please visit their website here to read the full article. In silico data generated using AI platforms can identify existing medication candidates and match them with diseases and conditions that don’t yet have a cure much quicker and...

Read more

Build a brand – not just a hotel

The hotel sector is changing and with that brings opportunity and challenge in equal measure. With increased competition from online accommodation websites like Airbnb and Homestay, hotels are having to reposition themselves and diversify to tap into a generation of guests who are looking for a more unique and immersive...

Read more

AI Accelerates Innovation

This article was originally posted on Communications of the ACM and remains their copyrighted material. Please visit their website here to read the full article. “To invent, you need a good imagination and a pile of junk.” So said Thomas Edison, America’s most prolific inventor. Yet the march of technology is now changing...

Read more